Navigation Links
Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
Date:7/18/2013

associated with CDI-related stays in the hospital were $8.2 billion in the U.S. during 2009. CDI is a rising global HAI problem in which the toxins produced by C. difficile bacteria result in diarrhea (C. difficile-associated diarrhea (CDAD)), and in the most serious cases, pseudomembranous colitis (erosion of the lower GI tract) that can lead to death. CDI is a major, unintended risk associated with the prophylactic or therapeutic use of intravenous antibiotics, which may alter the natural balance of microflora that normally protect the GI tract, leading to C. difficile overgrowth and infection. Other risk factors for CDI include hospitalization, prolonged length of stay, underlying illness, immune-compromising conditions including the administration of chemotherapy, and advanced age.

CDI is a widespread and often drug resistant infectious disease, and it is estimated that 1.1 million patients are infected with C. diff annually in the U.S.* Controlling the spread of CDI has proven challenging, as the C. difficile spores are easily transferred to patients via normal contact with healthcare personnel and other inanimate objects. There is currently no vaccine or approved product for the prevention of C. diff infection.

About Fujifilm Diosynth Biotechnologies (http://www.fujifilmdiosynth.com)

FUJIFILM Diosynth Biotechnologies UK Limited is an industry leading biologics Contract Development and Manufacturing Organization. Fujifilm Diosynth Biotechnologies has extensive experience in the development and manufacturing of recombinant proteins, vaccines, monoclonal antibodies, among other large molecules expressed in a wide array of microbial, mammalian, and insect systems. The company offers a comprehensive list of services from microbial and mammalian cell line development, including its proprietary pAVEway™ system, to process development, analytical develo
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability
2. Synthetic Biologics to Present at OneMedForum New York 2013
3. New England Biolabs supports iGEM synthetic biology competition
4. Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
5. Intrexon Organizes Around New Synthetic Biology Markets
6. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
7. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
8. Express Genes by Eurofins MWG Operon Offers 4 Day Delivery of Synthetic Genes
9. Top Ten Suppliers of Synthetic Biology Technology
10. Infectious Disease Specialist, Brad Spellberg, M.D., Joins Synthetic Biologics Scientific Advisory Board
11. Discovery in synthetic biology takes us a step closer to new industrial revolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Massachusetts , June 1, 2015 ... announces that it will be participating in the Jefferies ... NY on Tuesday, June 2, 2015. ... a question and answer session at 10:00 a.m. ET ... will be available on the Presentations and Webcasts section ...
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "2015 Strategies in the UK Flow ... This report presents a comprehensive analysis of ... Major issues pertaining to the French flow cytometry ... social and technological trends with significant market impact ...
(Date:6/1/2015)... June 1, 2015 Hutchison ... that AstraZeneca AB (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ... ongoing Phase Ib clinical trial of HMP,s c-Met ... AZD9291 in non-small cell lung cancer ("NSCLC"). ... epidermal growth factor receptor (EGFR). Preliminary data on ...
(Date:5/31/2015)... (PRWEB) May 31, 2015 The most ... Society of Clinical Oncology (ASCO) Annual Meeting – “The ... Lecture” – prominently featured presentations by immunotherapy experts and ... , James Patrick Allison, PhD, chairman of the Department ... Cancer Center and SITC committee member, received the Science ...
Breaking Biology Technology:Strategies in the UK Flow Cytometry Market 2015 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3SITC Reports on Immunotherapy Insights and Data Featured at ASCO Plenary Session 2
... April 28 PharmAthene, Inc. (NYSE Amex: PIP ... threats, today announced the appointment of Mitchel Sayare , Ph.D. ... members. , , ... Dr. Sayare most recently served as Chairman and Chief Executive Officer ...
... ... and Recognition of Science and Technology), a not-for-profit organization founded by inventor Dean Kamen ... Supplier of the FIRST Robotics Competition (FRC®). , ... (PRWEB) April 28, 2010 -- Haydon Kerk Motion Solutions, ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at ... Tuesday, May 4, 2010 at 10:40 a.m. ET / ... chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview. , ... The presentation will be webcast live through the ...
Cached Biology Technology:PharmAthene Appoints Mitchel Sayare, Ph.D. to the Company's Board of Directors 2PharmAthene Appoints Mitchel Sayare, Ph.D. to the Company's Board of Directors 3Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 2Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 3Haydon Kerk Motion Solutions Inspires Next Generation of Innovators as Silver Supplier of the FIRST Robotics Competition 4Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare Conference 2
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
(Date:4/20/2015)... 20, 2015 Huntington Memorial Hospital is the ... a new miniaturized, wireless monitoring sensor to manage heart ... and only FDA-approved heart failure monitoring device that has ... by physicians to manage heart failure. The ... in the pulmonary artery (PA) during a non-surgical procedure ...
(Date:4/17/2015)... 17, 2015 Increasing ... technological advancement to drive biometric systems market in ...   According to a recently released ... &  Opportunities, 2020 ", biometric systems market in ... growth at CAGR of over 22% through 2020. ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... an ongoing effort to mirror the ability of biological ... scientists from the McGowan Institute for Regenerative Medicine have ... both biological and chemical toxins. They described the findings ... biological principles to create materials that can do many ...
... University of Florida engineering researchers have found they can ... say opens the door to a wave of new technologies ... about the research appears in this week,s advance online edition ... Ben Koopman and Brij Moudgil say they used lasers not ...
... from the Robertson Foundation to create a state-of-the-art Translational ... cell therapy research and treatment programs for children and ... suffered at birth. In making the announcement, Victor J. ... Chief Executive Officer for Duke University Health System, said ...
Cached Biology News:Multifunctional polymer neutralizes both biological and chemical weapons 2Engineers: Weak laser can ignite nanoparticles, with exciting possibilities 2Engineers: Weak laser can ignite nanoparticles, with exciting possibilities 3Robertson Foundation donates $10.2 million for Duke Cell Therapy Center 2Robertson Foundation donates $10.2 million for Duke Cell Therapy Center 3